Cargando…
Radiation-induced skin reactions: mechanism and treatment
Radiotherapy (RT) is a major treatment for malignant tumors. The latest data show that >70% of patients with malignant tumors need RT at different periods. Skin changes can be experienced by up to 95% of patients who underwent RT. Inflammation and oxidative stress (OS) have been shown to be gener...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306060/ https://www.ncbi.nlm.nih.gov/pubmed/30613164 http://dx.doi.org/10.2147/CMAR.S188655 |
_version_ | 1783382703943450624 |
---|---|
author | Wei, Jinlong Meng, Lingbin Hou, Xue Qu, Chao Wang, Bin Xin, Ying Jiang, Xin |
author_facet | Wei, Jinlong Meng, Lingbin Hou, Xue Qu, Chao Wang, Bin Xin, Ying Jiang, Xin |
author_sort | Wei, Jinlong |
collection | PubMed |
description | Radiotherapy (RT) is a major treatment for malignant tumors. The latest data show that >70% of patients with malignant tumors need RT at different periods. Skin changes can be experienced by up to 95% of patients who underwent RT. Inflammation and oxidative stress (OS) have been shown to be generally associated with radiation-induced skin reactions (RISRs). Inflammatory response and OS interact and promote each other during RISRs. Severe skin reactions often have a great impact on the progress of RT. The treatment of RISRs is particularly critical because advanced RT technology can also lead to skin reactions. RISRs are classified into acute and chronic reactions. The treatment methods for acute RISRs include steroid treatment, creams, ointments, and hydrocolloid dressings, depending on the reaction grading. Chronic RISRs includes chronic ulcerations, telangiectasias, and fibrosis of the skin, and advanced treatments such as mesenchymal stem cells, hyperbaric oxygen therapy, superoxide dismutase, and low-intensity laser therapy can be considered. Here, we review and summarize the important mechanisms that cause RISRs as well as the standard and advanced treatments for RISRs. |
format | Online Article Text |
id | pubmed-6306060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63060602019-01-04 Radiation-induced skin reactions: mechanism and treatment Wei, Jinlong Meng, Lingbin Hou, Xue Qu, Chao Wang, Bin Xin, Ying Jiang, Xin Cancer Manag Res Review Radiotherapy (RT) is a major treatment for malignant tumors. The latest data show that >70% of patients with malignant tumors need RT at different periods. Skin changes can be experienced by up to 95% of patients who underwent RT. Inflammation and oxidative stress (OS) have been shown to be generally associated with radiation-induced skin reactions (RISRs). Inflammatory response and OS interact and promote each other during RISRs. Severe skin reactions often have a great impact on the progress of RT. The treatment of RISRs is particularly critical because advanced RT technology can also lead to skin reactions. RISRs are classified into acute and chronic reactions. The treatment methods for acute RISRs include steroid treatment, creams, ointments, and hydrocolloid dressings, depending on the reaction grading. Chronic RISRs includes chronic ulcerations, telangiectasias, and fibrosis of the skin, and advanced treatments such as mesenchymal stem cells, hyperbaric oxygen therapy, superoxide dismutase, and low-intensity laser therapy can be considered. Here, we review and summarize the important mechanisms that cause RISRs as well as the standard and advanced treatments for RISRs. Dove Medical Press 2018-12-21 /pmc/articles/PMC6306060/ /pubmed/30613164 http://dx.doi.org/10.2147/CMAR.S188655 Text en © 2019 Wei et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Wei, Jinlong Meng, Lingbin Hou, Xue Qu, Chao Wang, Bin Xin, Ying Jiang, Xin Radiation-induced skin reactions: mechanism and treatment |
title | Radiation-induced skin reactions: mechanism and treatment |
title_full | Radiation-induced skin reactions: mechanism and treatment |
title_fullStr | Radiation-induced skin reactions: mechanism and treatment |
title_full_unstemmed | Radiation-induced skin reactions: mechanism and treatment |
title_short | Radiation-induced skin reactions: mechanism and treatment |
title_sort | radiation-induced skin reactions: mechanism and treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306060/ https://www.ncbi.nlm.nih.gov/pubmed/30613164 http://dx.doi.org/10.2147/CMAR.S188655 |
work_keys_str_mv | AT weijinlong radiationinducedskinreactionsmechanismandtreatment AT menglingbin radiationinducedskinreactionsmechanismandtreatment AT houxue radiationinducedskinreactionsmechanismandtreatment AT quchao radiationinducedskinreactionsmechanismandtreatment AT wangbin radiationinducedskinreactionsmechanismandtreatment AT xinying radiationinducedskinreactionsmechanismandtreatment AT jiangxin radiationinducedskinreactionsmechanismandtreatment |